Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Invesco S&P 500 High Div Low Volatility ETF (SPHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Invesco S&P 500 High Div Low Volatility ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Invesco S&P 500 High Div Low Volatility ETF trades at $48.82 (market cap $3.14B). The key difference: Iovance Biotherapeutics Inc. Common Stock is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Invesco S&P 500 High Div Low Volatility ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Invesco S&P 500 High Div Low Volatility ETF for 125 Days on average.
| IOVA | SPHD | |
|---|---|---|
Market Cap | $6.04B | $3.14B |
Volume | 14,805,993 | 1,461,349 |
Sector | Health | — |
52-Week High | $14.82 | $53.55 |
52-Week Low | $1.81 | $46.96 |
Typical Hold Time | 0 Days | 125 Days |
Enterprise Value | $5.97B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPHD trades at $48.81, up 1.29% today, but faces bearish technical signals with 17 sell indicators versus 4 buy signals. The ETF's monthly dividend structure provides consistent income, though recent analysis highlights underperformance compared to peers like SCHD over the past decade. Current technical positioning shows oversold conditions with RSI readings below 15, suggesting potential for near-term bounce despite the dominant bearish trend.
The outlook remains cautious as SPHD's high-dividend, low-volatility strategy faces challenges in maintaining total returns. Key risks include yield trap exposure and weaker drawdown recovery compared to quality-focused alternatives. For income-focused investors, the monthly dividend provides utility, but long-term capital appreciation appears limited based on historical performance trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →
